Category: Health

Health

First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award

First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award

Virtual care company’s commitment to providing high-quality, delightful healthcare experiences is evolving workplace well-being.


CHICAGO, July 20, 2023 (Newswire.com)
–
First Stop Health (FSH), a leading virtual care company for primary, urgent and mental health care needs, is proud to announce its recognition as a winner of the esteemed 2023 Well-Being Trailblazer Award. Presented by Archetype and the Wellness Council of America (WELCOA), this prestigious award celebrates FSH’s contributions to the well-being industry and its commitment to transforming workplace wellness. 

“When we provide new services, we do so for the betterment of our users – employees and their family members across the country. That desire is what drove our decision to launch Virtual Primary Care in 2022,” said FSH CEO, Teira Gunlock. “We are excited to be considered a Trailblazer for our approach in delivering convenient, compassionate care.” 

“These remarkable companies are leading the way in transforming the well-being landscape, and we have full confidence that they will continue to drive positive change in the sphere of workplace well-being,” commented Iain Fitzpatrick, Chief Strategy Officer at Archetype. “Their innovative approaches and unwavering commitment to improving employee well-being are shaping the future of the industry.” 

Presented by Archetype and the Wellness Council of America (WELCOA), the Well-Being Trailblazer Awards celebrate innovative companies reshaping workplace wellness. These prestigious awards recognize organizations enhancing employee well-being, promoting resilience, and setting new standards for well-being technology, products, and services. 

FSH is proud to provide care that people love® and its +94 Virtual Primary Care Net Promoter Score (NPS) reflects its commitment to members’ well-being. FSH virtual care is designed to promote equitable, culturally competent and quality-assured healthcare to support the unique needs of patients. 

About First Stop Health 

First Stop Health (FSH) provides care that people love with various digital healthcare services. Patients can access virtual care 24/7 via app, website or phone. We help them save time and money with safe, convenient, high-quality virtual care solutions – Primary Care, Urgent Care & Mental Health. FSH was named one of Inc. Magazine’s Best Workplaces of 2022 and 2023, and ranked one of the fastest-growing private companies for the past five years by Inc. 5000. FSH was also recognized in Crain’s Chicago Business Fast 50 and ranked one of the Chicago area’s fastest-growing companies.    

Contact Information:

Emily Kunisch

Senior Manager, Marketing

[email protected]

888-691-7867 x-410

Original Source:

First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award

The post First Stop Health Honored as Winner of the 2023 Well-Being Trailblazer Award first appeared on Enrose Magazine.

Continue Reading

Health

Dr. Eric Grigsby Collaborates on Groundbreaking Study of Donanemab’s Impact on Alzheimer’s Disease

Dr. Eric Grigsby Collaborates on Groundbreaking Study of Donanemab’s Impact on Alzheimer’s Disease

Neurovations Research proud to be a part of study that released first positive results to slow Alzheimer’s Disease


NAPA, Calif., July 19, 2023 (Newswire.com)
–
Neurovations, a leading medical research and innovation company, is proud to have collaborated on a groundbreaking study investigating the effects of the monoclonal antibody, donanemab, on patients with the early stages of Alzheimer’s Disease.

Neurovations began enrolling patients in 2021 in advance of Eli Lilly’s recent announcement of positive results from the TRAILBLAZER-ALZ 2 Phase 3 trial. This study demonstrated that donanemab significantly slowed cognitive and functional decline in individuals with early Alzheimer’s Disease.

“We are thrilled to be part of this vital research. Alzheimer’s Disease affects nearly 1 million people in my home state of California,” said Dr. Eric Grigsby. “This is a significant step forward in the fight against Alzheimer’s, and we are optimistic about the impact this treatment may have on the members of my community with this condition.”

Neurovations was founded in Napa in 1992 by Dr. Eric Grigsby and is a national leader in clinical research for pain and neurologic diseases, treatment for chronic pain, molecular diagnostics testing, and education programs focused on pain and neuroscience. 

The TRAILBLAZER-ALZ 2 study, a randomized, double-blind, placebo-controlled trial, evaluated the safety and efficacy of donanemab, an investigational, amyloid-targeting therapy. Participants with early symptomatic Alzheimer’s disease were enrolled in the study, and those with confirmed presence of AD neuropathology completed their course of treatment with donanemab.

Neurovations Research was selected as a study site in 2021 and worked with Eli Lilly to contribute to this groundbreaking research. Dr. Grigsby’s expertise and passion for advancing treatments for neurodegenerative diseases and chronic pain have been instrumental in the success of this collaboration.

Key findings from the TRAILBLAZER-ALZ 2 study include:

●   Nearly half (47%) of participants on donanemab showed no clinical progression at one year, defined as no decline in Clinical Dementia Rating-Sum of Boxes (CDR-SB), compared to 29% of participants on placebo.

●   Donanemab treatment slowed clinical decline by 35% compared to placebo, leading to a 40% reduction in the decline of activities of daily living.

These results have significant implications for the treatment of early symptomatic Alzheimer’s disease and have prompted Lilly to move forward with FDA approval and global regulatory submissions. Neurovations and Dr. Eric Grigsby’s involvement in this study have further enhanced the research community’s understanding of the potential benefits of donanemab in Alzheimer’s disease management.

“Alzheimer’s Disease affects an estimated 6.7 million Americans aged 65 and older. This first step is monumental on the path to a cure. We are thrilled to have been part of the study and sincerely hope to begin offering the treatment as soon as possible,” stated Dr Grigsby.

Contact Information:

Krista Clark

Marketing Director

[email protected]

7072529665

Original Source:

Dr. Eric Grigsby Collaborates on Groundbreaking Study of Donanemab’s Impact on Alzheimer’s Disease

The post Dr. Eric Grigsby Collaborates on Groundbreaking Study of Donanemab’s Impact on Alzheimer’s Disease first appeared on Enrose Magazine.

Continue Reading

Health

Panoramic Health Propels Integrated Value-Based Care in Texas Through a Strategic Partnership With San Antonio Kidney Disease Center

Panoramic Health Propels Integrated Value-Based Care in Texas Through a Strategic Partnership With San Antonio Kidney Disease Center

Panoramic Health, the Largest Physician-Led CKCC Participant, Drives Integrated, Value-Based Care to Patients With CKD-ESRD in South Texas Through Its Partnership With San Antonio Kidney Disease Center
…

The post Panoramic Health Propels Integrated Value-Based Care in Texas Through a Strategic Partnership With San Antonio Kidney Disease Center first appeared on Enrose Magazine.

Continue Reading

Health

VidaTalk’s Talk-to-Translate Feature Will Have a Transformative Impact on Hospitalized Patients With Language Barriers

VidaTalk’s Talk-to-Translate Feature Will Have a Transformative Impact on Hospitalized Patients With Language Barriers

Achieving the standard of care, no matter the language or disability.


ANN ARBOR, Mich., July 19, 2023 (Newswire.com)
–
Vidatak is proud to announce the latest feature, Talk-to-Translate, has just been added to VidaTalk to better ensure providers can deliver equitable care to patients with communication barriers and disabilities on a 24/7 basis.

VidaTalk is a first-in-kind, multilingual, point-of-care communication solution for patients with speech, hearing and language barriers. This customizable app for patients and providers includes picture-option communication selections that generate bilingual text and audio output when selections are made across 40 language profiles, relaxation videos, therapeutic restorative music, video and audio interpreter access, talk-to-text, and now, talk-to-translate. The new talk-to-translate feature released today ensures that even under the rarest circumstances, patients and providers will be able to understand one another.

Language barriers pose significant challenges in healthcare where effective and timely communication is vital. While in-person and remote video and telephonic interpreter services provide this essential service as the standard of care, they simply are not always feasible or available with every patient encounter, especially for languages spoken with lower frequency. 

With delayed or absent access to interpreters, providers find themselves unable to communicate with or understand their patients. This communication gap exposes patients to significant risk of harm, misdiagnosis, delayed diagnosis, and delayed or absent treatment. While for complex conversations, such as discharge instructions, Google Translate has been shown to be unreliable, in certain circumstances, it may be necessary.

“As VidaTalk continues to harness the technologies that drive equitable experiences for vulnerable patient populations, it is essential for hospitals to consider what their standard of care actually delivers with respect to a real-time multilingual experience and a human-centered approach to care.” – Dr. Patak, CEO of Vidatak

Vidatak’s Chief Experience Officer, Lisa Spencer, shares a personal experience she had with a loved one: “My family member could not communicate his needs and symptoms. It was frustrating and heartbreaking for everyone. I’m not alone. Every hospital is caring for patients with speech, hearing and language barriers. For patients that don’t speak the same language as their caregivers, using certified interpreters is the gold standard; but, when no one with language services is available, patients still need to communicate. That’s why I’m so excited that VidaTalk now has this new talk-to-translate feature. No one deserves to suffer or be in pain for hours, or even an entire weekend, simply because an interpreter can’t be reached.”

By ensuring that multilingual communication can occur in real time at the point of care, VidaTalk validates the highest standard of care, establishing a mechanism for effective communication for patients who have speech, hearing or language barriers. This vital connection can alleviate patient distress, enhance trust, and contribute to a more positive healthcare experience. When patients feel understood and supported, they are more likely to actively engage in their own healthcare journey, leading to better compliance, faster recovery, and enhanced overall well-being.

VidaTalk has revolutionized the healthcare experience for hospitalized patients who cannot speak, cannot hear, or have limited English proficiency. “As VidaTalk continues to harness the technologies that drive equitable experiences for vulnerable patient populations, it is essential for hospitals to consider what their standard of care actually delivers with respect to a real-time multilingual experience and a human-centered approach to care,” states Dr. Patak, CEO of Vidatak.

Contact Information:

Lance Patak

CEO

[email protected]

(323) 697-9906

Lisa Spencer

Chief Experience Officer

[email protected]

‭(425) 247-4007‬



Related Files
Adults with Communication Disabilities Experience Poorer Health and Healthcare Outcomes Compared to Persons Without Communicatio
Giving Voice- Nurse-Patient Communication in the Intensive Care Unit.pdf

Related Images

Original Source:

VidaTalk’s Talk-to-Translate Feature Will Have a Transformative Impact on Hospitalized Patients With Language Barriers

The post VidaTalk’s Talk-to-Translate Feature Will Have a Transformative Impact on Hospitalized Patients With Language Barriers first appeared on Enrose Magazine.

Continue Reading